Given that obesity is a chronic and relapsing disease, it is important to understand the effectiveness of different strategies to maintain WL: TRIUMPH-6 (NCT06859268) will assess changes in bodyweight at 116 weeks in individuals with obesity who have completed 80 weeks of retatrutide, comparing continued treatment at high or low doses of retatrutide versus switching to placebo for the last 36 weeks
While the health benefits of weight loss are significant, the cosmetic concerns of Ozempic face are valid
The FDA recently sent warning letters to several companies distributing the unapproved drug, notifying them that theyre violating federal law
At the time, his wife had found success with Saxenda, a drug whose active ingredient, liraglutide, is FDA-approved for chronic weight management
The short half-life means drug accumulation from a double dose can cause severe GI side effects
Both are available as weekly subcutaneous injections, and both are widely used as compounded formulations
